James M. Hoffman

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)

Kelly E. Caudle, Henry M. Dunnenberger, Robert R. Freimuth et al. · Genetics in Medicine · 2016 · 548 citations · Full text

Medicine, Genetics, Pharmacology +17

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process

Kelly E. Caudle, Teri E. Klein, James M. Hoffman et al. · Current Drug Metabolism · 2014 · 436 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics

James M. Hoffman, Cyrine E. Haidar, Mark R. Wilkinson et al. · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 2014 · 271 citations · Full text

Medicine, Pharmacology, Medical Genetics +14

The Second Victim Experience and Support Tool: Validation of an Organizational Resource for Assessing Second Victim Effects and the Quality of Support Resources

Jonathan D. Burlison, Susan D. Scott, Emily Browne et al. · Journal of Patient Safety · 2014 · 271 citations

Social Sciences, Organizational Behavior, Psychology +13

Development and use of active clinical decision support for preemptive pharmacogenomics

Gillian C. Bell, Kristine R. Crews, Mark R. Wilkinson et al. · Journal of the American Medical Informatics Association · 2013 · 209 citations · Full text

Medicine, Health Informatics, Pharmacology +17